Stock Locations

New Jersey, USA
Czech Republic, EU
Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

154361-50-9Capecitabine Working Standard (Secondary Reference Standard)

● Under Development

Catalogue No.:	VE0026846
CAS No.:	154361-50-9
Mol. Formula:	C15H22FN3O6
Mol. Weight:	359.35 g/mol

How can we help?

Add to RFQ list

Additional information on CAS 154361-50-9

Parent drug

Capecitabine

IUPAC Name

(Pentyl 1-(5-deoxy-β-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinecarbamate)

Pharmacopeial Synonyms

N/A

Synonyms

N/A

Smiles

O=C1N([C@@H]2O[C@H](C)[C@@H](O)[C@H]2O)C=C(F)C(NC(OCCCCC)=O)=N1

InChI

InChI=1S/C15H22FN3O6/c1-3-4-5-6-24-15(23)18-12-9(16)7-19(14(22)17-12)13-11(21)10(20)8(2)25-13/h7-8,10-11,13,20-21H,3-6H2,1-2H3,(H,17,18,22,23)/t8-,10-,11-,13-/m1/s1

Description

Capecitabine Working Standard (Secondary Reference Standard), CAS 154361-50-9, is supplied for analytical method development and laboratory research. It is intended solely for research and analytical method development and is not certified for use as a primary reference standard for GMP QC batch release or regulatory stability studies. This secondary standard is characterized to support calibration, method validation and system suitability testing, accompanied by batch-specific documentation including certificate of analysis and chromatographic profile. Packaged under controlled conditions to preserve integrity, this working standard facilitates reproducible assay performance and traceable analytical workflows in non-regulatory research environments.